References
- Amichai , B. , Grunwald , M. H. and Brenner , L. 2001 . Fexofenadine Hydrochloride—A new anti‐histaminic drug . Isr. Med. Assoc. J. , 3 : 207 – 209 .
- Breier , A. R. , Menegola , J. , Paim , C. S. , Steppe , M. and Schapoval , E. E.S. 2004 . Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules . J. of AOAC Int. , 87 : 1093 – 1097 .
- Breier , A. R. , Garcia , S. S. , Jablonski , A. , Steppe , M. and Schapoval , E. E.S. 2005 . J. of AOAC Int. , 88 : 1059 – 1063 .
- Borade , P. S. , Ballary , C. C. , Currie , G. P. and Lee , D. K.S. 2006 . Modern H1‐antihistamines in asthma . Drug Disc Today: Ther Strategies. , 3 : 253 – 259 .
- Ermer , J. 2001 . Validation in pharmaceutical anallysis. Part I: An integrated approach . J. Pharm. Biomed. Anal. , 24 : 755 – 767 .
- Estelle , F. and Simons , R. 2002 . Antihistamines in Allergy , 2nd Edn. Edited by: Kaplan , A. P. 834 – 863 . Philadelphia : W.B. Saunders Company .
- Fu , I. , Woolf , E. J. and Matuszewski , B. K. 2004 . Determination of fexofenadine in human plasma using 96‐well solid phase extraction and HPLC with tandem mass spectrometric detection . J. Pharm. Biomed. Anal. , 35 : 837 – 846 .
- Gazy , A. A. , Mahgoub , H. , El‐Yazbi , F. A. , El‐Sayed , M. A. and Youssef , R. M. 2002 . Determination of some histamine H1‐receptor antagonists in dosage forms . J, Pharm, Biomed, Anal. , 30 : 859 – 867 .
- Gergov , M. , Robson , J. N. , Ojanperä , I. , Heinonen , O. P. and Vuori , E. 2001 . Simultaneous screening and quantitation of 18 antihistamine drugs in blood by liquid chromatography ionspray tandem mass spectrometry . Forensic Sci. Int. , 121 : 108 – 115 .
- Hofmann , U. , Seiler , M. , Drescher , S. and Fromm , M. F. 2002 . Determination of fexofenadine in human plasma and urine by liquid chromatography‐mass spectrometry . J. Chrom. B. , 766 : 227 – 233 .
- ICH . International Conference on Harmonisation of Technical requirements for registration of pharmaceuticals for human use ,
- Kawashima , M. and Harada , S. 2007 . Effect of standard medication on quality of life of patients with atopic dermatitis . J. Dermatol. , 34 : 9 – 16 .
- Markham , A. and Wagstaff , A. J. 1998 . Fexofenadine . Drugs , 55 : 269 – 274 .
- Mikus , P. , Valásková , I. and Havránek , E. 2005 . Determination of fexofenadine in tablets by capillary electrophoresis in free solution and in solution with cyclodextrins as analyte carriers . Drug Dev. and Ind. Pharm. , 31 : 795 – 801 .
- Radhakrishna , T. and Reddy , G. O. 2002 . Simultaneous determination of fexofenadine and its related compounds by HPLC . J. Pharm. Biomed. Anal. , 24 : 755 – 767 .
- Simpson , K. and Jarvis , B. 2000 . Fexofenadine a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria . Drugs , 59 : 301 – 321 .
- The Merck . 2001 . The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals Whitehouse Station NJ : Merck & CO., INC. .
- Uno , T. , Yasui‐Furukori , N. , Takahata , T. , Sugawara , K. and Tateishi , T. 2004 . Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection . J. Pharm. Biomed. Anal. , 35 : 937 – 942 .
- USP 30 . 2007 . The United States Pharmacopoeia , 29th Edn. Rockville : United States Pharmacopeial Convention. .